Christopher J. Ott

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Abstract B014: Transcription factors governing the evolution of drug-tolerant persisters in KRAS-mutant non-small cell lung cancer

  Cancer Research · 2025-12-04

• Abstract B083: Transcription factors enhancing anti-tumor chemokine expression and lymphocyte infiltration in KRAS G12C inhibitor-resistant non-small cell lung cancer

  Molecular Cancer Therapeutics · 2025-10-22

• ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3

  Blood Cancer Discovery · 2025-10-17 · 1 citations

• p300/CBP is an essential driver of pathogenic enhancer activity and gene expression in Ewing sarcoma

  EMBO Reports · 2025-09-01 · 7 citations

• Supplementary Fig. S2 from Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer ModelsPreprint

  2025-06-04

• Data from Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer ModelsPreprint

  2025-06-04

• Supplementary Fig. S1 from Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer ModelsPreprint

  2025-06-04

• Supplementary Fig. S3 from Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer ModelsPreprint

  2025-06-04

• Suppl. Tab. 1 from Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer ModelsPreprint

  2025-06-04

• Suppl. Tab. 2 from Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer ModelsPreprint

  2025-06-04

• Supplementary Fig. S7 from Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer ModelsPreprint

  2025-06-04

• Supplementary Fig. S6 from Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer ModelsPreprint

  2025-06-04

• Supplementary Fig. S4 from Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer ModelsPreprint

  2025-06-04

• Supplementary Fig. S5 from Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer ModelsPreprint

  2025-06-04

• Correction: DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming

  Cancer Discovery · 2025-04-02

• Targeted degradation of CDK9 potently disrupts the MYC-regulated network

  Cell chemical biology · 2025-03-29 · 10 citations

• Supplementary Figures S1-S8 from DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingPreprint

  2025-02-21

• Supplementary Tables S1-S7 from DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming

  2025-02-21

• Contents of Supplementary Tables from DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming

  2025-02-21

• Supplementary Tables S1-S7 from DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming

  2025-02-07